Immediate postpartum cessation of tenofovir did not increase risk of virological or clinical relapse in highly viremic pregnant mothers with chronic hepatitis B infection
JHEP Rep. 2024 Feb 28;6(5):101050. doi: 10.1016/j.jhepr.2024.101050. eCollection 2024 May. ABSTRACT BACKGROUND & AIMS: Peripartum prophylaxis (PP) with tenofovir disoproxil fumarate (TDF) is the standard …